Europe’s first and last field trial of gene-edited plants?

Europe’s first and last field trial of gene-edited plants?
复制标题

欧洲第一次也是最后一次基因编辑植物的田间试验?

DOI:
10.7554/elife.42379
复制
发表时间:
2018
期刊:
影响因子:
7.7
通讯作者:
J. Napier
J. Napier
中科院分区:
生物学1区
文献类型:
--
作者:
J. Faure;J. Napier

文献摘要

被引文献

相似文献

今年6月5日,CRISPR-Cas-9基因编辑作物的首次田间试验在英国的Rothamsted Research开始,并获得了英国环境、食品和农村事务部的批准。然而,2018年7月下旬,审判开始后,欧洲法院裁定基因编辑等技术属于欧盟2001年转基因指令的范围,这意味着我们的基因编辑山茶花植物应被视为转基因(GM)。在这里,我们描述了我们的经验,运行这个试验和法律的改造我们的工厂。我们还考虑了使用基因编辑技术的欧洲植物研究的未来,这些技术现在属于转基因监管的负担,以及这将如何阻碍公共资助的基础研究的转化。
On 5 June this year the first field trial of a CRISPR-Cas-9 gene-edited crop began at Rothamsted Research in the UK, having been approved by the UK Department for Environment, Food & Rural Affairs. However, in late July 2018, after the trial had started, the European Court of Justice ruled that techniques such as gene editing fall within the European Union’s 2001 GMO directive, meaning that our gene-edited Camelina plants should be considered as genetically modified (GM). Here we describe our experience of running this trial and the legal transformation of our plants. We also consider the future of European plant research using gene-editing techniques, which now fall under the burden of GM regulation, and how this will likely impede translation of publicly funded basic research.